Semiconductor-based materials to help facial and skull bone gaps heal faster
Official title: Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven Approach
Funded at University of Texas Arlington · NIH-11295452 · Data updated 2026-11-12
New bioengineered bone materials aim to speed healing of large facial bone defects and help blood vessels grow back so reconstruction works better for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project start | March 3, 2023 |
| Project end | February 28, 2028 |
| Funding year | 2026 |
| Award (this year) | $454,596 |
| NIH project number | 5R01DE031872-04 |
| Project ID | NIH-11295452 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with large or 'critical-size' craniofacial bone defects from trauma or surgical removal of lesions who need reconstruction would be the primary candidates for this work as it moves toward clinical testing.
✕Less likely to help
Patients with small fractures that normally heal on their own, non-bone conditions, or active infections that preclude implantation are unlikely to benefit directly from this research in the near term.
What this research studies
This project is designing new biomaterials that combine structural strength with chemical signals to boost bone-forming stem cells and blood vessel cells. Scientists will tune material chemistry, add antioxidant activity, and build nanoscale layers to encourage cell migration, mineral growth, and angiogenesis. Work includes lab tests with human cells and preclinical models to measure strength, healing, and inflammation compared with current options. If successful, the materials could be adapted into implants or coatings used during reconstructive surgery.
Why it matters
Potential benefit: If successful, these materials could speed repair of large craniofacial bone defects, reduce the need for donor bone grafts, and lower complications like swelling from current growth-factor treatments.
How similar studies have gone: Some existing approaches like autografts, titanium hardware, or growth-factor treatments can help but have limits such as donor-site problems or harmful swelling, and this semiconductor-inspired biomaterial strategy is a novel, mostly preclinical approach that has not yet been proven in humans.
Where this research is happening
-
University of Texas Arlington
Arlington, United States Active
Researchers
- Principal investigator: Varanasi, Venu Gopal — University of Texas Arlington
- Study coordinator: Varanasi, Venu Gopal
Related research
Other NIH-funded projects on the same topics.
-
New microfluidic platform to study aging and reproduction in C. elegans
Aims to make studying aging and reproductive biology in C. elegans easier and faster by using a new microfluidic chip that automates how worms are loaded, housed, and imaged.
-
Unlocking how transcriptional regulators influence eye health and disease
A patient-friendly overview of a research project that aims to map how genes control eye health using scalable, advanced data methods.
-
Data-driven look at walkability and safety for older adults
A small, patient-friendly study aims to understand what makes neighborhoods easier or harder to walk for adults aged 21 and older, focusing especially on older adults.
-
How changes to public spaces affect hypertension risk in older adults
changes in everyday public spaces like parks and sidewalks may influence blood pressure in adults 21 and older over time.
-
Improving Teenage Driver Safety through Better Training and Safer Roadways
A teen-focused program tests how strengthening driver training and smarter road design can reduce risky driving and crashes for 15–18-year-olds.
-
Light-activated metal tools to image and treat disease
A researcher team at a university is developing tiny osmium metal compounds that light up and can be activated inside the body to help visualize and control disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.